Wu, Xuehong
Feng, Wanru
Yang, Mao
Liu, Xunxi
Gao, Mengdi
Li, Xinghai
Gan, Lin
He, Tao
Funding for this research was provided by:
Department of Science and Technology of Sichuan Province (2018HH0023)
Article History
Received: 18 March 2022
Revised: 8 June 2022
Accepted: 24 June 2022
First Online: 12 August 2022
Declarations
:
: X Li is an employee and a shareholder of Hinova Pharmaceuticals Inc. Other authors have no competing interest to disclose.
: All of the study designs and test procedures were performed in accordance with the Helsinki Declaration II. The animal protocols were approved by the Ethics Committee of Southwest Medical University, Sichuan, China.